- Home
- IMRX vs TMQ Comparison
IMRX vs TMQ Comparison
Compare IMRX & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRX
- TMQ
- Stock Information
- Founded
- IMRX 2008
- TMQ 2004
- Country
- IMRX United States
- TMQ Canada
- Employees
- IMRX N/A
- TMQ N/A
- Industry
- IMRX Biotechnology: Pharmaceutical Preparations
- TMQ Precious Metals
- Sector
- IMRX Health Care
- TMQ Basic Materials
- Exchange
- IMRX Nasdaq
- TMQ Nasdaq
- Market Cap
- IMRX 73.2M
- TMQ 83.6M
- IPO Year
- IMRX 2021
- TMQ N/A
- Fundamental
- Price
- IMRX $1.78
- TMQ $1.10
- Analyst Decision
- IMRX Buy
- TMQ
- Analyst Count
- IMRX 7
- TMQ 0
- Target Price
- IMRX $12.80
- TMQ N/A
- AVG Volume (30 Days)
- IMRX 801.9K
- TMQ 439.1K
- Earning Date
- IMRX 11-13-2024
- TMQ 02-07-2025
- Dividend Yield
- IMRX N/A
- TMQ N/A
- EPS Growth
- IMRX N/A
- TMQ N/A
- EPS
- IMRX N/A
- TMQ N/A
- Revenue
- IMRX N/A
- TMQ N/A
- Revenue This Year
- IMRX N/A
- TMQ N/A
- Revenue Next Year
- IMRX N/A
- TMQ N/A
- P/E Ratio
- IMRX N/A
- TMQ N/A
- Revenue Growth
- IMRX N/A
- TMQ N/A
- 52 Week Low
- IMRX $1.00
- TMQ $0.25
- 52 Week High
- IMRX $8.07
- TMQ $1.40
- Technical
- Relative Strength Index (RSI)
- IMRX 37.40
- TMQ 51.44
- Support Level
- IMRX $1.52
- TMQ $1.08
- Resistance Level
- IMRX $1.93
- TMQ $1.20
- Average True Range (ATR)
- IMRX 0.19
- TMQ 0.08
- MACD
- IMRX -0.05
- TMQ -0.02
- Stochastic Oscillator
- IMRX 21.95
- TMQ 38.46
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
About TMQ Trilogy Metals Inc.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-lead-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.